Baker McKenzie advised global pharmaceuticals company Sanofi in the sale of Genfar, its generics business in Colombia, Ecuador and Peru, to Eurofarma Laboratorios S.A.
Serving as lead counsel, Baker McKenzie advised Sanofi on all key legal aspects of the transaction. The core cross-border team was led by Alan Zoccolillo, Laura Estrada Vasquez and Sarah Rodrigue in the United States and Jaime Trujillo and David Mayorga in Bogotá.
The deal is emblematic of the breadth and depth of Baker McKenzie's cross-border experience advising healthcare and life sciences companies on their most business critical transactions. As one of the first law firms to advise life sciences corporates on their global expansion 60 years ago, the firm's knowledge is rooted in its DNA, with more than 800 dedicated lawyers focused on the industry in more than 45 jurisdictions, including the 10 largest life sciences markets globally.
Located in financial centers and emerging markets, Baker McKenzie is a market-leader in cross-border and global reorganization transactions, planning, managing and implementing multi-billion dollar complex M&A, spin-off, post-acquisition integration and similar projects across numerous jurisdictions. The seasoned transactional team provides seamless counsel through local excellence, deep sector knowledge, commercial acumen and refined transactional techniques to maximize deal certainty and deliver maximum value to clients.